REGENERON PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Tarrytown, NY
SEC filing record 1 source field available
Fiscal year end
31 December
REGENERON PHARMACEUTICALS, INC. has filed 2,454 SEC EDGAR filings since 26 Jul 1995

SEC filing history

Showing 76-83 of 83 matching filings.

Per page
25
Current page
4
SC 13G/A File 005-41938

REGN AS OF 12/31/2010

Filing date
11 Jan 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41938

REGENERON PHARMACEUTICALS SC 13G/A 9-20-2010

Filing date
20 Sep 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41938

SEC FILING

Filing date
12 Jul 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41938

DOC ONE

Filing date
10 Jun 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-41938

DOC ONE

Filing date
16 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-41938

SEC FILING

Filing date
12 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-41938

REGN AS OF 12/31/2009

Filing date
11 Feb 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-41938

SC 13G filing

Filing date
29 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .